More on BEAM

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (6.9 Score)
- Holders
- Dividends (3.4% Yield)

Upcoming Events

- Earnings (8/12/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Beam Therapeutics Inc. (NQ:BEAM)
Delayed: 26.54 +1.02 (4.00%)
Prev. Close $25.52  
Open$24.60 
52 Wk High$83.60 
52 Wk Low$82.96 
Day High$26.96 
Day Low$24.60 
P/E 11.85  
EPS$2.24 
Volume1,607,991 

Friends, Peers and Foes (?): NTLA, CRSP, ALNY, BHVN, BMRN (more...)

Mar 5, 2026 04:06 PM Form 8-K Beam Therapeutics Inc. For: Mar 02
Mar 3, 2026 07:21 AM H.C. Wainwright Reiterates Buy Rating on Beam Therapeutics Inc (BEAM)
Feb 26, 2026 04:08 PM Form 4 Beam Therapeutics Inc. For: Feb 24 Filed by: Ciaramella Giuseppe
Feb 26, 2026 05:52 AM Beam Therapeutics Inc (BEAM) PT Lowered to $40 at Bernstein; 'Shares Still Undervalued'
Feb 25, 2026 09:04 AM Beam Therapeutics Inc (BEAM) PT Raised to $26 at RBC Capital
Feb 24, 2026 04:16 PM Form 144 Beam Therapeutics Inc. Filed by: Ciaramella Giuseppe
Feb 24, 2026 11:49 AM Beam Therapeutics Inc (BEAM) PT Raised to $47 at BofA Securities
Feb 24, 2026 07:23 AM Form S-8 Beam Therapeutics Inc.
Feb 24, 2026 07:11 AM Form 10-K Beam Therapeutics Inc. For: Dec 31
Feb 24, 2026 07:06 AM Form 8-K Beam Therapeutics Inc. For: Feb 24
View All Articles

Entities mentioned with BEAM

View All Entities